Cash grants

Between cycles

Funds an early-career researcher's kidney cancer project alongside paired mentoring inside the program's own investigator academy.

Between cycles

Funds an early-stage kidney cancer research idea built on a clear hypothesis and a strong scientific rationale.

Between cycles

Funds an early-stage, high-risk lung cancer research idea, with a separate track for investigators new to independent research.

Between cycles

Funds patient-centered research into lung cancer outcomes and survivorship, done alongside a patient or survivor advocate.

Between cycles

Funds translational lung cancer research moving toward the clinic, at either a late preclinical stage or a pilot clinical trial.

Between cycles

Funds a multi-investigator research program tackling one shared question in rare melanoma, split across two or three linked projects.

Between cycles

Funds an exploratory, high-risk melanoma research idea, where existing preliminary data is discouraged rather than expected.

Between cycles

Funds an early-career melanoma researcher's project alongside guided mentoring inside the program's own academy.

Between cycles

Funds research into the health, quality of life and well-being of melanoma survivors, their families and care partners.

Between cycles

Funds a multi-investigator melanoma research team through a pre-application screen, with each partner named on their own award.

Between cycles

Funds early, untested ideas in combat-relevant burn care meant to generate the preliminary data a later study would need.

Between cycles

Funds the earliest, most speculative stage of a neurofibromatosis idea, before any preliminary data exists.

Between cycles

Funds established neurofibromatosis research addressing a critical need, with an optional level adding collaboration or open data sharing.

Between cycles

Funds two senior neurofibromatosis investigators to direct a mentoring academy for early-career scholars, with a shared pilot project.

Between cycles

Funds an early-career investigator's neurofibromatosis project inside a mentored research academy, guided by a designated Career Guide.

Between cycles

Funds 2 to 3 investigators jointly pursuing one new idea in neurofibromatosis, with each partner named on a separate award.

Between cycles

Funds clinical trials of ovarian cancer drugs, biologics, devices or guidance, from small pilots to large efficacy studies.

Between cycles

Funds a small, patient-centred pilot in pancreatic cancer research, meant to produce the preliminary data a bigger study would need.

Between cycles

Funds high-risk, high-reward pancreatic cancer research ideas, with an optional funding boost for pairing an early-career investigator with a mentor.

Between cycles

Funds a required clinician-scientist partnership in pancreatic cancer research, the only sibling award here that allows a pilot clinical trial.

Between cycles

Funds cancer clinical trials from first-in-human through phase III, with regulatory filings already due at the application deadline.

Between cycles

Funds untested, high-risk basic cancer research ideas, explicitly excluding incremental advances or a model swapped from one cancer to another.

Between cycles

Funds computational and AI research that mines large prostate cancer datasets for insight, not new lab experiments.

Between cycles

Funds a first prostate cancer research project for a scientist within three years of their postdoc, guided by an experienced mentor.